Abstract
Lenalidomide and Eltrombopag for Treatment in Low or Intermediate Risk Myelodysplastic Syndrome: Result of a Phase 2 Study Combination Clinical Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have